Single-cell metabolic activity analysis demonstrated that, relative to normal liver tissue, the metabolic activity of most core pathways—excluding linoleic acid metabolism—was significantly enhanced in tumor-killing cells, including CD8+ T cells, CD4+ T cells, macrophages, dendritic cells, monocytes, and proliferative T cells, aligning with findings from metabolomics analyses. This evidence concerns the gene CD4 and neoplasm.